View Future GrowthPaltac 과거 순이익 실적과거 기준 점검 1/6Paltac의 수입은 연평균 -3.6%의 비율로 감소해 온 반면, Retail Distributors 산업은 수입이 연평균 11.8% 감소했습니다. 매출은 연평균 4.2%의 비율로 증가해 왔습니다. Paltac의 자기자본이익률은 7.3%이고 순이익률은 1.8%입니다.핵심 정보-3.64%순이익 성장률-2.04%주당순이익(EPS) 성장률Retail Distributors 산업 성장률20.65%매출 성장률4.19%자기자본이익률7.30%순이익률1.78%다음 순이익 업데이트03 Aug 2026최근 과거 실적 업데이트공고 • Jun 09Paltac Corporation to Report Q1, 2027 Results on Aug 03, 2026Paltac Corporation announced that they will report Q1, 2027 results on Aug 03, 2026공고 • May 10Paltac Corporation to Report Fiscal Year 2026 Results on May 11, 2026Paltac Corporation announced that they will report fiscal year 2026 results on May 11, 2026공고 • Dec 02Paltac Corporation to Report Q3, 2026 Results on Feb 06, 2026Paltac Corporation announced that they will report Q3, 2026 results on Feb 06, 2026공고 • Sep 02Paltac Corporation to Report Q2, 2026 Results on Nov 04, 2025Paltac Corporation announced that they will report Q2, 2026 results on Nov 04, 2025모든 업데이트 보기Recent updates공고 • Jul 14Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)공고 • Jul 08MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. As of June 19, 2026, S.T. Corporation has resolved to tender its 339,000 shares. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation. MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders on July 7, 2026. A total of 24,466,104 shares were tendered, which was above the minimum number of shares to be purchased (8,676,100 shares). MediPal Holdings Corporation plans to implement a series of procedures to make the Tender Offeror the sole shareholder of Paltac Corporation (the “Squeeze-out Procedures”). Upon completion, the shares of Paltac Corporation will be delisted from the Prime Market of the Tokyo Stock Exchange.공고 • Jun 19Paltac Corporation Announces Management ChangesPaltac Corporation announced that, at a meeting of the Board of Directors held on June 19, 2026, it resolved to make changes in its directors and executive officers. Masahiro Noma was redesignated from Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters to Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters, General Manager of Logistics Headquarters. Masashi Gotan retired from the position of Executive Officer, General Manager of Logistics Headquarters and was attached to the General Affairs Headquarters.공고 • Jun 09Paltac Corporation to Report Q1, 2027 Results on Aug 03, 2026Paltac Corporation announced that they will report Q1, 2027 results on Aug 03, 2026공고 • May 12MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation.공고 • May 11Paltac Corporation, Annual General Meeting, Jun 19, 2026Paltac Corporation, Annual General Meeting, Jun 19, 2026.공고 • May 10Paltac Corporation to Report Fiscal Year 2026 Results on May 11, 2026Paltac Corporation announced that they will report fiscal year 2026 results on May 11, 2026공고 • Dec 02Paltac Corporation to Report Q3, 2026 Results on Feb 06, 2026Paltac Corporation announced that they will report Q3, 2026 results on Feb 06, 2026공고 • Sep 02Paltac Corporation to Report Q2, 2026 Results on Nov 04, 2025Paltac Corporation announced that they will report Q2, 2026 results on Nov 04, 2025매출 및 비용 세부 내역Paltac가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이OTCPK:PCCO.F 매출, 비용 및 순이익 (JPY Millions)날짜매출순이익일반관리비연구개발비31 Mar 261,237,84622,03165,922031 Dec 251,227,66921,90264,922030 Sep 251,212,80522,10563,520030 Jun 251,201,23023,02862,231031 Mar 251,188,09722,86461,088031 Dec 241,179,98821,77660,468031 Mar 241,151,96620,63859,2170양질의 수익: PCCO.F는 고품질 수익을 보유하고 있습니다.이익 마진 증가: PCCO.F의 현재 순 이익률 (1.8%)은 지난해 (1.9%)보다 낮습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 지난 5년 동안 PCCO.F의 연간 수익 성장률이 양(+)이었는지 판단하기에 데이터가 부족합니다.성장 가속화: PCCO.F은 지난 1년 동안 수익이 감소하여 5년 평균과 비교할 수 없습니다.수익 대 산업: PCCO.F은 지난 1년 동안 수익이 감소(-3.6%)하여 Retail Distributors 업계 평균(-19%)과 비교하기 어렵습니다.자기자본이익률높은 ROE: PCCO.F의 자본 수익률(7.3%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YRetail 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/23 20:22종가2026/05/11 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Paltac Corporation는 4명의 분석가가 다루고 있습니다. 이 중 3명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Oliver James Gray MatthewCLSAYumiko KaiIchiyoshi Research Institute Inc.Kyoichiro ShigemuraNomura Securities Co. Ltd.1명의 분석가 더 보기
공고 • Jun 09Paltac Corporation to Report Q1, 2027 Results on Aug 03, 2026Paltac Corporation announced that they will report Q1, 2027 results on Aug 03, 2026
공고 • May 10Paltac Corporation to Report Fiscal Year 2026 Results on May 11, 2026Paltac Corporation announced that they will report fiscal year 2026 results on May 11, 2026
공고 • Dec 02Paltac Corporation to Report Q3, 2026 Results on Feb 06, 2026Paltac Corporation announced that they will report Q3, 2026 results on Feb 06, 2026
공고 • Sep 02Paltac Corporation to Report Q2, 2026 Results on Nov 04, 2025Paltac Corporation announced that they will report Q2, 2026 results on Nov 04, 2025
공고 • Jul 14Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)
공고 • Jul 08MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. As of June 19, 2026, S.T. Corporation has resolved to tender its 339,000 shares. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation. MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders on July 7, 2026. A total of 24,466,104 shares were tendered, which was above the minimum number of shares to be purchased (8,676,100 shares). MediPal Holdings Corporation plans to implement a series of procedures to make the Tender Offeror the sole shareholder of Paltac Corporation (the “Squeeze-out Procedures”). Upon completion, the shares of Paltac Corporation will be delisted from the Prime Market of the Tokyo Stock Exchange.
공고 • Jun 19Paltac Corporation Announces Management ChangesPaltac Corporation announced that, at a meeting of the Board of Directors held on June 19, 2026, it resolved to make changes in its directors and executive officers. Masahiro Noma was redesignated from Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters to Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters, General Manager of Logistics Headquarters. Masashi Gotan retired from the position of Executive Officer, General Manager of Logistics Headquarters and was attached to the General Affairs Headquarters.
공고 • Jun 09Paltac Corporation to Report Q1, 2027 Results on Aug 03, 2026Paltac Corporation announced that they will report Q1, 2027 results on Aug 03, 2026
공고 • May 12MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation.
공고 • May 11Paltac Corporation, Annual General Meeting, Jun 19, 2026Paltac Corporation, Annual General Meeting, Jun 19, 2026.
공고 • May 10Paltac Corporation to Report Fiscal Year 2026 Results on May 11, 2026Paltac Corporation announced that they will report fiscal year 2026 results on May 11, 2026
공고 • Dec 02Paltac Corporation to Report Q3, 2026 Results on Feb 06, 2026Paltac Corporation announced that they will report Q3, 2026 results on Feb 06, 2026
공고 • Sep 02Paltac Corporation to Report Q2, 2026 Results on Nov 04, 2025Paltac Corporation announced that they will report Q2, 2026 results on Nov 04, 2025